Stock Analysis of Akili Inc (AKLI) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code AKLI
Close 0.427
Change -0.0172 / 3.87 %
Volume 227721
Vol Change -531375.00 / 70.00 %
IndustryHealth Information Services
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Poor Growth Stock
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Akili Inc


Highs/Lows of Akili Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.4016 6.37 % 1.85 % 0.44890.395409-May-2406-May-24
Two Week0.245 74.37 % 2.41 % 0.4850.220230-Apr-2429-Apr-24
One Month0.2467 73.17 % 1.20 % 0.4850.2130-Apr-2417-Apr-24
Three Month0.239 78.74 % 3.90 % 0.73840.191226-Feb-2423-Feb-24
Six Months0.43 0.651 % 18.29 % 0.73840.191226-Feb-2423-Feb-24
One year1.25 65.82 % 26.22 % 1.670.191209-Jun-2323-Feb-24


Technical View of Akili Inc






Charts of Akili Inc


Returns of Akili Inc with Peers
Period / StockAKLIRNLXSNCENUTXSPRB
1 Week6.37%-11.87%0.349%-7.19%11.86%
1 Mth73.17%-27.72%1.23%-35.33%11.06%
3 Mth78.74%61.90%32.49%-62.28%-80.77%
6mth-0.651%-32.20%7.28%-82.47%-20.70%
1 Year-65.82%-74.61%20.29%-92.75%-63.87%
2 Year--85.45%-94.10%-99.16%-41.77%
5 Years-----
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Akili Inc with Peers
Ratio / StockAKLIRNLXSNCENUTXSPRB
PE-0.562-282.77-0.272-0.0215-494.64
P/B0.4042364.850.3750.0034270.91
ROA-53.68-155.35-106.49-3.36-41.96
ROE-71.90-836.32-137.84-16.04-54.77
Debt To Equity0.2351.7300.2120.0436
Revenue1040.00 K
221.98 %
3403.00 K
14.58 %
60261.00 K
14.09 %
231700 K
5.66 %
7202.00 K
266.70 %
Net Income-65161.00 K
242.25 %
-45607.00 K
19.61 %
-124651.00 K
144.47 %
-28920.89 K
93.19 %
-49113.00 K
6.35 %


Technicals of Akili Inc with Peers
Technical / StockAKLIRNLXSNCENUTXSPRB-
ADX38.4015.5822.2824.2343.40
CMF-0.334-0.1760.079-0.139-0.067
MFI96.6162.0867.8252.7785.22
RSI67.8437.7657.5933.3638.73
MACD Abv SignalTrueFalseFalseTrueTrue
Price Above 50 MATrueFalseTrueFalseFalse-
Price Above 200 MAFalseFalseFalseFalseFalse-


About : Akili Inc


Address : No. 312, 71 Commercial Street, Boston, MA, United States, 02109
Tel : 617 313 8853
URL : https://www.akiliinteractive.com
Code : AKLI, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 19_Aug_2022
Employee Count : 68

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)